EN DE
Watch Synthomer plc for free: we tell you when fair value or trend changes.
Data-driven stock valuation

Synthomer plc (SYNT) fair value: what the stock is really worth

As of Nov 12, 2026: fair value (intrinsic value) of Synthomer plc stock £1.82, price £1.14, upside +59.1%, quality 34 out of 100. Rating: strongly undervalued. Calculated from audited financials with 9 of our 26 valuation models and 37 quality factors, updated daily.

  1. Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free

Basic Materials GB · ISIN GB00BNTVWJ75

SP Synthomer plc logo Some data Nov 8, 2026

Synthomer plc

SYNT · LSE

Cheap (37% below fair value) and rising price, but weak company: meets 2 of 3 rules.

Get notified free when this changes
Fair value £1.82 · Strongly undervalued 
Rising price (uptrend) 
Moderate debt 
Mixed vs. peers (5/12) 
Some data 
Profit last quarter 61% below a year ago. 
Quality 34/100 
Weak Growth (revenue 5y +1.1 %/yr in GBP) 
Loss-making · -6.7% net margin (TTM) 
Negative free cash flow over the last twelve months 
Narrow moat 17/100 · thin data
⟳ Cyclical
Watch Synthomer plc for free: we tell you when fair value or trend changes. Watch for free

What runs behind every stock

26 valuation models 8 families, DCF to NCAV 37 quality factors margins, balance sheet, cashflow, debt 6 AI factors moat, what no ratio measures 2,000+ data points verified, per stock, median

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

£36.80 £0.1780 Fair Value £1.82 Aug 2021 Nov 2026

White line = price, green steps = our fair value per fiscal year. As of Nov 8, 2026.

How to read this chart

60‑month range £0.1780 – £36.80 · fair‑value band £0.4600 – £3.26 · the £1.14 price screens below the £1.82 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 8, 2026.

Follow Synthomer in your weekly email

Every Wednesday you see whether Synthomer is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Synthomer plc manufactures and supplies specialised polymers and ingredients for coatings, construction, adhesives, and health and protection sectors.

Show moreShow less

The company offers adhesives, such as PSA labels, packaging and specialty tapes, and tape saturants; release coating, wood working, sealants, wet glues, hygiene, and contact adhesives; packaging and assembly hot melt adhesives and polymer under the AERAFIN brand name; and liquid polybutadiene products under the LITHENE brand.

It also provides architectural, intumescent, metal, and wood coating, as well as masonry, protective film, soil release, polyester for powder coating, horizontal surfaces, additives, and other products; binder; resins under the PLIOLITE brand name; coalescing agents and glycol/diol under SYNTHOMER NX and SYNOXOL BEPD brands; and construction products, as well as operates data centers.

In addition, the company offers building materials, industrial, hygiene, tyre and rubber, home textile, and consumer product; health and protection products, such as medical and examination gloves, coated fabric, industrial and fabric supported gloves, medical devices, personal care and food additives, hygiene adhesives, non-wovens, footwear, hygiene, and wipes; performance materials, including Alcotex polyvinyl alcohol (PVOH) for PVC, Vinaltex Polyvinyl Acetate, elastomeric modifier, resins for rubber compounds, tyre cord, monomers, Wingstay antioxidants, tyre additives, 3D printing, plastics modifiers for packaging, and PLASTVANCE T; energy solutions; paper and carpet products; and latex foam under Liponan Terra brand.

It operates in the United Kingdom, Germany, Italy, the Netherlands, France, Belgium, Spain, other Europe, Malaysia, China, Other Asia, the United States, and internationally. The company was formerly known as Yule Catto & Co. plc and changed its name to Synthomer plc in 2012.

Synthomer plc was founded in 1863 and is headquartered in London, the United Kingdom.

Stock analysis

Synthomer plc (SYNT) currently trades at £1.14, while our model-based Fair Value estimate is £1.82, implying the stock looks roughly 37% undervalued today.

Show more

Valuation

Bull case: the Multiples group reads highest at a median of £1.84 per share, and 5 of the 9 models we run sit above the £1.14 price.

Bear case: the Growth DCF group reads lowest at £1.15, and 4 of the 9 models stay below the price. Data coverage for this calculation is medium.

Scenario range: £0.4600 (bear) to £3.26 (bull), the price of £1.14 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 34/100 (below-average quality), in the Basic Materials sector.

Weak Growth: Growth has flattened: the last year, three and five years all grew more slowly than the long-term average.

Synthomer plc reported revenue of £1.7B in FY2025 versus £2.1B in FY2021, a compound −5.1%/yr. Reported net income was −£157M in FY2025.

Key figures

Market cap £187M Micro · P/S ratio 0.10 · EPS (TTM) £−0.7400 · Net margin −6.7% · Return on equity −13.2% · Return on assets (EBIT) 2.6% (5-year average) · Operating margin 4.2% · Revenue (TTM) £1.8B.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 17 out of 100 (low confidence).

What moves the price

The share trades about 6% below its 52-week high and 543% above its 52-week low, currently above its 200-day average.

For context, the median of 10 Basic Materials peers we cover trades at −42% fair-value upside, at 59%, SYNT screens cheaper than that median.

Fair Value models

Bear £0.4600 Fair Value £1.82 Bull £3.26
Price £1.14 · Upside +59.1%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Best data coverage
FCF DCF £0.6300 £1.91 £3.39 76
Growth DCF £0.6500 £1.79 £3.03 75
5Y Revenue Exit n/a £0.4300 £1.62 69
All 9 models by family
DCF Models
FCF DCF £0.6300 £1.91 £3.39 76
5Y Revenue Exit n/a £0.4300 £1.62 69
5Y EBITDA Exit £0.4000 £2.19 £4.18 69
10Y Revenue Exit n/a £0.8300 £1.91 64
10Y EBITDA Exit £0.4600 £1.82 £3.47 63
Multiples
EV/EBITDA £0.4200 £1.84 £3.26 60
Asset-Based
NCAV (Graham) £0.1300 £0.1700 £0.2500 54
Growth DCF
Growth DCF £0.6500 £1.79 £3.03 75
Rev-Margin DCF n/a £0.5100 £1.73 69

Open the full fair value analysis →

Quality Score breakdown

Overall quality 34/100

It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.

Profitability 13
How much profit the company makes from its sales and capital
Quality Growth 27
Are margins and returns getting better?
Cashflow 20
Do the profits arrive as real cash?
Financial strength 35
Debt, balance sheet and risk of trouble
Investment 94
Does it invest with discipline instead of growing at any price?
Low Volatility 31
How calm the share price moves, does not count
Price momentum 73
Price momentum of the last 3 to 12 months, does not count
Near the 52-week high 96
Distance to the 52-week high, does not count
New shares 40
Buys back shares or issues new ones?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 25/100
Growth has flattened: the last year, three and five years all grew more slowly than the long-term average.
Revenue growth 1 year
−12.5%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−9.3%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+1.1%
Start year 2020 (pandemic). Over 10 years: +7.2% a year
Revenue growth 40 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+7.8%
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
3.6% (2020) → −0.4% (2025)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss
not computed

Growth Forecast

A lot of optimism in the price
The price assumes more growth than the company has delivered so far and more than analysts expect.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+18.6%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect ⓘAnalysts publish sales forecasts for the next two fiscal years. For the years after that, growth slows evenly to 2 % a year by year ten (2 % is the long-run rate our models use). Projected years are marked as such.
+2.8%
Yearly sales growth analysts expect, extended to five years.
Calculated on free cash flow for fiscal year 2025. Over the last twelve months it was negative, so the figure above is uncertain.
After inflation (UK: IMF forecast 2.3% a year to 2030, 3.3% from 2016 to 2025) that is about +15.9% a year for the price and +0.4% for the forecasts.
Forecast 2026 (sales)+6.1%
Forecast 2027 (sales)+1.9%
Projected 2028 (sales)+1.9%
Projected 2029 (sales)+2.0%
Projected 2030 (sales)+2.0%

Watch SYNT, get fair value alerts →

Compare Synthomer plc with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Specialty Chemicals · 755 stocks

Beats the industry median on 5/11 measures
A mixed picture versus its industry peers.
Valuation
Quality Score 34 · Bottom 25%
Fair Value upside +59.1% · Top 25%
Profitability
Return on assets −6.9% · Bottom 25%
Net margin (12 months) −6.7% · Bottom 25%
Operating margin (12 months) 4.2% · Below median
Growth and dividend
Revenue growth (quarter YoY) 6.7% · Below median
Balance sheet
Debt / equity 0.85× · Highest 25%

Valuation Multiplesvs Specialty Chemicals median · lower = cheaper

P/B 0.21× · Cheapest 25%
P/S (12 months) 0.10× · Cheapest 25%
Price / free cash flow (fiscal year) 5.1× · Cheapest 25%
EV/EBITDA 6.8× · Cheaper than median

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)100 · sector 5
FUTURE (revenue growth)34 · sector 65
PAST (return on equity)0 · sector 26
HEALTH (low debt)58 · sector 95
DIVIDEND (yield)0 · sector 30

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Specialty Chemicals stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value Compare
Wanhua Chemical Group 600309 ¥68.92 ¥68.03 −1% vs SYNT
Linde plc LIN $522.49 $446.62 −15% vs SYNT
PPG Industries, Inc PPG $122.35 $77.68 −37% vs SYNT
DSM-Firmenich AG DSFIR CHF 97.20 CHF 58.28 −40% vs SYNT
Asian Paints Limited ASIANPAINT ₹2,537 ₹1,479 −42% vs SYNT
The Sherwin-Williams Company SHW $351.39 $152.59 −57% vs SYNT
Givaudan SA GIVN CHF 4,091 CHF 1,629 −60% vs SYNT
EMS-CHEMIE HOLDING AG EMSN CHF 848.00 CHF 284.63 −66% vs SYNT
Ecolab Inc ECL $304.41 $97.18 −68% vs SYNT
Air Products and Chemicals, Inc APD $316.20 $75.33 −76% vs SYNT

Explore undervalued stocks

More undervalued Basic Materials stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend StocksUndervalued 52-Week Low StocksStocks for 2027: Large Companies Below Fair Value

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

Stock screenerFilter by region, size and sector Compare toolTwo stocks side by side Average Down CalculatorFree calculator
Run the numbers yourself: free valuation calculators
DCF CalculatorP/E Ratio CalculatorPEG Ratio CalculatorGraham NumberPeter Lynch FormulaDDM CalculatorIntrinsic ValueIntrinsic vs Extrinsic ValueP/E Ratio by Sector
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Synthomer plc: fair value per Fair Value Calculator

Cite: Fair Value Calculator (2026). "Synthomer plc Fair Value". https://www.fairvalue-calculator.com/stock/SYNT

Frequently asked questions

Is Synthomer plc (SYNT) overvalued or undervalued?
As of Nov 8, 2026, our model estimates a fair value of £1.82 versus a price of £1.14, about +59% upside (undervalued).
What is the fair value of SYNT?
Our model-based fair value for Synthomer plc is £1.82 (as of Nov 8, 2026), built from audited fundamentals. The current price: £1.14.
What is the quality score of SYNT?
Synthomer plc has a Quality Score of 34/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Synthomer plc (SYNT)?
Our model-based price target is the fair value of £1.82 (as of Nov 8, 2026) from 9 valuation models. Cautious scenario £0.4600, optimistic scenario £3.26. It is a calculation from audited fundamentals, not an analyst target.
What is the Synthomer plc stock forecast for 2026?
Our models put fair value at £1.82, about +59% upside versus a price of £1.14 (undervalued). Cautious scenario £0.4600, optimistic scenario £3.26. The calculation is refreshed regularly with new filings.
What is the revenue of Synthomer plc (SYNT)?
Synthomer plc reported trailing-twelve-month revenue of about £1.8B (latest available figure, as of Nov 8, 2026).
What growth is priced into Synthomer plc (SYNT)?
For today's price to be fair in a discounted-cash-flow model, Synthomer plc would have to grow free cash flow by +18.6 % per year for five years (discount rate 13.3 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +1.1 % per year. Calculated on free cash flow for fiscal year 2025. Over the last twelve months it was negative, so the figure above is uncertain. As of Nov 8, 2026.
What discount rate (WACC) does the fair value of SYNT use?
Our models discount Synthomer plc at 13.3 %: a base by market capitalisation (micro), damped by beta 1.00, country premium for United Kingdom. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Synthomer plc that is +18.6 % per year for five years, then slowing evenly to 2 % by year ten, using the same discount rate (13.3 %) and the same formula as our fair value.
How much growth has Synthomer plc (SYNT) delivered so far?
Over the past 5 years revenue at Synthomer plc grew +1.1 % a year. The price currently implies free-cash-flow growth of +18.6 % per year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Synthomer plc (SYNT) growing?
The median revenue growth in the sector is +8.7 % a year. That is the yardstick for the growth priced into Synthomer plc (+18.6 % per year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Synthomer plc (SYNT)?
The free-cash-flow yield on the price is 19.57 % in the last fiscal year (free cash flow was negative over the last twelve months): that much free cash flow Synthomer plc produces per unit of market value. When it exceeds the discount rate of our models (13.3 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Synthomer plc (SYNT)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Synthomer plc it is £1.82 per share (as of Nov 8, 2026), against a price of £1.14. It is the blended result of 9 valuation models in 4 families (DCF Models, Multiples, Asset-Based, Growth DCF).
Is Synthomer plc stock overvalued or undervalued in 2026?
As of Nov 8, 2026, SYNT trades below its calculated fair value: price £1.14, fair value £1.82, a gap of about +59% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of SYNT?
No. The price is what the market pays today (£1.14); the fair value is what the company's own numbers justify (£1.82). For Synthomer plc the two are £0.6760 per share apart. That gap is exactly why we show both numbers side by side.
How much is Synthomer plc worth?
The market values Synthomer plc at about £187M (market capitalisation, as of Nov 8, 2026). Per share that is £1.14; our models calculate a fair value of £1.82 per share.
What do the bullish and bearish scenarios say about SYNT?
Our models span a range for Synthomer plc: cautious scenario £0.4600, base £1.82, optimistic £3.26 per share (as of Nov 8, 2026, price £1.14). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Synthomer plc (SYNT)?
Balance-sheet figures for Synthomer plc (as of Nov 8, 2026): return on equity −13.2%, debt of 0.85 per unit of equity. They feed the Quality Score of 34/100, which measures business quality independently of the share price.
How far is SYNT from its 52-week high?
Synthomer plc trades at £1.14, about 6% below its 52-week high of £1.22 and 543% above the low of £0.1780 (as of Nov 12, 2026). Distance from the high says nothing about value: that is what the fair value of £1.82 is for.
Which stocks are comparable to Synthomer plc?
From the same area (Basic Materials) we also value Linde plc, Ecolab Inc, The Sherwin-Williams Company, Air Products and Chemicals, Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Synthomer plc stock attractive at the current price?
The data as of Nov 8, 2026: price £1.14, calculated fair value £1.82 (+59%), Quality Score 34/100, from 9 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of SYNT calculated?
We run Synthomer plc through 9 models from 4 families: DCF Models, Multiples, Asset-Based, Growth DCF. Every model gets the same audited fundamentals; the fair value of £1.82 builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.3% above its aggregate fair value. Synthomer plc currently trades 37% below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Synthomer plc (SYNT)?
The closing price on Nov 12, 2026 was £1.14. Our model-based fair value is £1.82, about +59% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Synthomer plc right now?
The large discount to fair value meets weak quality (34/100). That raises the risk this is a value trap rather than a bargain. The model range is unusually wide (£0.4600 to £3.26). The outcome hinges heavily on assumptions, so read the point estimate with caution.

Key figures of Synthomer plc

How large is the market capitalisation of Synthomer plc (SYNT)?
The market capitalisation of Synthomer plc is £187M. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Synthomer plc (SYNT)?
The price-to-sales ratio of Synthomer plc is 0.10 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Synthomer plc (SYNT)?
Earnings per share at Synthomer plc are £−0.7400. Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of Synthomer plc (SYNT)?
The net margin of Synthomer plc is −6.7% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Synthomer plc (SYNT)?
The return on equity (ROE) of Synthomer plc is −13.2% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Synthomer plc (SYNT)?
On an EBIT basis the return on assets of Synthomer plc is 2.6% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Synthomer plc (SYNT)?
The operating margin of Synthomer plc is 4.2% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Synthomer plc (SYNT)?
Revenue at Synthomer plc is growing +6.7% versus a year earlier (3y avg −9.3%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Synthomer plc (SYNT)?
Earnings per share at Synthomer plc are growing −61.2% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net debt does Synthomer plc (SYNT) carry?
The net debt of Synthomer plc is £629M (fiscal year 2025, ≈ 17.2 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed

Watch Synthomer plc in the live analysis

One click puts Synthomer plc on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.